CSIMarket
 


Atyr Pharma Inc  (LIFE)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atyr Pharma Inc's Leverage Ratio for Trailing Twelve Months Period

LIFE's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

LIFE Leverage Ratio for Trailing Twelve Months Period

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Growth 18.03 % 49.74 % 19.68 % 18.9 % 42.33 %
Y / Y Total Liabilities Growth -55.95 % -52.83 % -44.29 % -38.16 % -39.7 %
Leverage Ratio for Trailing Twelve Months Period 0.22 0.29 0.37 0.44 0.52
Total Ranking # 477 # 568 # 651 # 799 # 948
Seq. Equity Growth 57.32 % -1.61 % -10.96 % -14.37 % 99.6 %
Seq. Total Liabilities Growth -23.32 % -25.32 % -17.34 % -6.96 % -17.88 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to debt repayement of -23.32% Atyr Pharma Inc decreased Leverage Ratio for Trailing Twelve Months Period in the I. Quarter to 0.22, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 66 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Atyr Pharma Inc. While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 477, from total ranking in previous quarter at 568.

What is Leverage Ratio?
Who are LIFE's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 67
Sector # 228
S&P 500 # 475


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.49 0.75 0.11
(Sep. 30, 2009)   (March 31, 2016)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2021, within Biotechnology & Drugs Industry Leverage Ratio for Trailing Twelve Months Period
Armata Pharmaceuticals Inc   0.60 
Aclaris Therapeutics Inc   0.60 
Eiger Biopharmaceuticals Inc   0.56 
Meridian Bioscience Inc   0.56 
Windtree Therapeutics Inc  0.55 
Scholar Rock Holding Corp  0.55 
Strongbridge Biopharma plc  0.54 
Voyager Therapeutics Inc   0.53 
Beam Therapeutics Inc   0.52 
Cellectis S a   0.52 
Myriad Genetics Inc   0.52 
Gossamer Bio Inc   0.52 
Brainstorm Cell Therapeutics inc   0.52 
Relay Therapeutics Inc   0.51 
Livongo Health Inc   0.50 
Axcella Health Inc   0.47 
Quidel Corporation  0.46 
Volitionrx Ltd  0.46 
Vericel Corporation  0.45 
Tracon Pharmaceuticals Inc   0.44 
Precipio Inc   0.44 
Tg Therapeutics inc   0.43 
Axon Enterprise inc   0.43 
Bio techne Corp  0.43 
Fate Therapeutics inc   0.42 
Orgenesis Inc   0.40 
Phathom Pharmaceuticals Inc   0.39 
Oncocyte Corp  0.38 
Applied Genetic Technologies Corp  0.38 
Innovage Holding Corp   0.38 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ONVO's Profile

Stock Price

ONVO's Financials

Business Description

Fundamentals

Charts & Quotes

ONVO's News

Suppliers

ONVO's Competitors

Customers & Markets

Economic Indicators

ONVO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071